STAT5B and breast carcinoma: Identifying key signaling pathways and regulatory molecules, such as PIAS3, PIP, STAT5, and SOCS3 in breast cancer (BC) cells, can provide valuable insights into the mechanisms of the disease and potentially lead to the development of targeted therapies.